Growth Metrics

Innoviva (INVA) Change in Accured Expenses: 2010-2025

Historic Change in Accured Expenses for Innoviva (INVA) over the last 15 years, with Sep 2025 value amounting to -$16.5 million.

  • Innoviva's Change in Accured Expenses fell 314.89% to -$16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.5 million, marking a year-over-year decrease of 37.85%. This contributed to the annual value of $3.0 million for FY2024, which is 303.20% up from last year.
  • According to the latest figures from Q3 2025, Innoviva's Change in Accured Expenses is -$16.5 million, which was down 344.77% from $6.7 million recorded in Q2 2025.
  • Innoviva's 5-year Change in Accured Expenses high stood at $9.7 million for Q2 2022, and its period low was -$16.5 million during Q3 2025.
  • Moreover, its 3-year median value for Change in Accured Expenses was -$3.5 million (2023), whereas its average is -$3.5 million.
  • In the last 5 years, Innoviva's Change in Accured Expenses skyrocketed by 446.14% in 2022 and then slumped by 1,363.53% in 2024.
  • Over the past 5 years, Innoviva's Change in Accured Expenses (Quarterly) stood at -$2.5 million in 2021, then grew by 22.46% to -$1.9 million in 2022, then tumbled by 83.07% to -$3.5 million in 2023, then dropped by 12.79% to -$4.0 million in 2024, then crashed by 314.89% to -$16.5 million in 2025.
  • Its Change in Accured Expenses stands at -$16.5 million for Q3 2025, versus $6.7 million for Q2 2025 and -$4.8 million for Q1 2025.